EV/EBITDA
N/A
27 min ago
Summary
- CANF EV/EBITDA is not available.
Performance
CANF EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CANF EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | -6.8% | -3.3% |
| 1 m1 month | - | -25.1% | -13.4% |
| 3 m3 months | - | -50.9% | -32.4% |
| 6 m6 months | - | -55.6% | -42.0% |
| ytdytd | - | -23.4% | -12.3% |
| 1 y1 year | - | -23.0% | -31.7% |
| 5 y5 years | - | -46.2% | -93.3% |
CANF EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | -0.59 | -0.99 | ||
| 3 y | 3-year | -0.46 | -2.23 | ||
| 5 y | 5-year | -0.25 | -3.95 | ||
| alltime | all time | 0.09 | -10.28 |
Can-Fite BioPharma EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | -0.66(-51.1%) |
| 2022 | -1.35(-43.8%) |
| 2021 | -2.40(+75.2%) |
| 2020 | -1.37(+53.9%) |
| 2019 | -0.89(-75.0%) |
| 2018 | -3.56(+7.9%) |
| Date | Value |
|---|---|
| 2017 | -3.30(+11.1%) |
| 2016 | -2.97(-18.9%) |
| 2015 | -3.66(-18.1%) |
| 2014 | -4.47(-12.7%) |
| 2013 | -5.12(+23.1%) |
| 2012 | -4.16 |
FAQ
- What is the all time high EV/EBITDA for Can-Fite BioPharma?
What is the all time high EV/EBITDA for Can-Fite BioPharma?
Can-Fite BioPharma all-time high EV/EBITDA is 0.09